Degang Li

Title: Degang Li: Innovator in Pharmaceutical Development

Introduction

Degang Li is a prominent inventor based in Anhui, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have important therapeutic applications. With a total of 4 patents to his name, Li's work has the potential to impact the medical community significantly.

Latest Patents

Li's latest patents include a guanidyl-containing P2Y12 receptor antagonist and a preparation method and application thereof. This P2Y12 receptor antagonist, which contains a guanidyl, is particularly noteworthy for its ability to inhibit platelet aggregation. The compound is described as a pyridazinone-guanidine compound, which can be utilized in preparing anti-platelet aggregation pharmaceutical compositions.

Another significant patent involves a novel intermediate used for preparing tapentadol and its analogs. This invention not only improves the product yield and quality of tapentadol but also reduces production costs and simplifies the production process. The environmentally friendly preparation process aligns well with the requirements of industrial production.

Career Highlights

Degang Li has worked with Anhui New Star Pharmaceutical Development Co., Ltd., where he has contributed to various innovative projects. His experience in the pharmaceutical industry has equipped him with the knowledge and skills necessary to develop effective therapeutic compounds.

Collaborations

Li has collaborated with notable colleagues such as Ziao Xu and Xiaoxiang Li. These partnerships have likely enhanced his research and development efforts, leading to successful innovations in the pharmaceutical field.

Conclusion

Degang Li's contributions to pharmaceutical development through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.